Fertility tracking bracelet, Ava, closes $30m

by Startacus Admin

Zurich-based Ava, makers of the first fertility tracking sensor bracelet, closes a $30m Series B funding round and announces 10,000th “Ava” pregnancy.

It's fair to say there has been a rise in the FemTech market over the last few years with the sector emerging as the likely next big disruptor in the global health care market. With fertility monitoring still not particularly tech friendly - think urinating on ovulation sticks and constantly checking temperatures, it would be an area of the FemTech market that would be primed for disruption. 

Step forward, Ava, a fertility tracking sensor bracelet and the only femtech company to have had the findings of a clinical trial peer reviewed and published in a leading science magazine. 

The key finding of the clinical trial was that a woman’s pulse is the best way to identify (in real time) more fertile days / cycle, pregnand thus increase the chances of conception.

Ava frees women from having to use outdated, invasive and inaccurate fertility monitoring methods, detecting 5.3 fertile days / cycle - in real time - while in the privacy of a user's home. With this previously only done via repeated overnight sessions in a hospital / clinic, the tracking sensor bracelet is a massive advance in empowering women to to take control of their reproductive health via data insights and science.

$30m Series B funding round

The majority of Ava’s new financing came from existing investors, with prominent European VC firms btov and SVC also joining the round.

Ava also announced today that its cycle-tracking sensor bracelet, which precisely detects the 5.3-day fertile window in a woman’s cycle in real time, has officially reached a milestone of 10,000 pregnancies among users since launching in July 2016.

According to Ava Co-Founder Pascal Koenig, Ava will use the new funds for further product research and development to enhance the existing product and create new applications that empower women to take control of their reproductive health via data insights and science.

“Ava’s long-term vision is to accompany women through all stages of their reproductive life by providing data-driven, clinically proven technology that will make a woman’s life easier, healthier and better -- be it when they just want to understand their body, while they are trying to prevent pregnancy, trying to get pregnant, are pregnant or entering menopause,” Koenig explained.

Subscribe to our newsletter

If you would like to receive our startup themed newsletter, full of the latest startup opportunities, events, news, stories, tips and advice, then sign up here.

• #femtech
• #ava
• #fertility
• #pregnancy
• #wearable
• #wearable tech
• #medtech
• #
• #vc
• #venture capital

Published on: 30th May 2018